Asbestos-induced cellular and molecular alteration of immunocompetent cells and their relationship with chronic inflammation and carcinogenesis

Journal of Biomedicine and Biotechnology

Volumn 2012, Issue , 2012, Pages

  Matsuzaki, Hidenori ^a   Maeda, Megumi ^a,b   Lee, Suni ^a   Nishimura, Yasumitsu ^a   Kumagai Takei, Naoko ^a   Hayashi, Hiroaki ^a   Yamamoto, Shoko ^a   Hatayama, Tamayo ^a   Kojima, Yoko ^c   Tabata, Rika ^c   Kishimoto, Takumi ^c   Hiratsuka, Junichi ^a   Otsuki, Takemi ^a  

^a KAWASAKI MEDICAL SCHOOL   (Japan)

^b OKAYAMA UNIVERSITY   (Japan)

^c OKAYAMA ROSAI HOSPITAL   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

ASBESTOS; CHEMOKINE RECEPTOR CXCR3; GAMMA INTERFERON; INTERLEUKIN 6; SILICON DIOXIDE;

BLOOD SAMPLING; CARCINOGENESIS; CHRONIC INFLAMMATION; HUMAN; IMMUNOCOMPETENT CELL; IN VITRO STUDY; MESOTHELIOMA; NONHUMAN; PLEURA DISEASE; REVIEW; TUMOR IMMUNITY; ANIMAL; ASBESTOSIS; AUTOIMMUNITY; CELL TRANSFORMATION; CHEMICALLY INDUCED DISORDER; CHEMISTRY; CHRONIC DISEASE; IMMUNOLOGY; INFLAMMATION;

ANIMALS; ASBESTOS; ASBESTOSIS; AUTOIMMUNITY; CELL TRANSFORMATION, NEOPLASTIC; CHRONIC DISEASE; HUMANS; INFLAMMATION; MESOTHELIOMA;

EID: 84863230484     PISSN: 11107243     EISSN: 11107251     Source Type: Journal    
DOI: 10.1155/2012/492608     Document Type: Review

References (81)

1. Craighead J. E., Gibbs A. R., Asbestos and Its Diseases 2008 New York, NY, USA Oxford University Press
2. Dodson R. F., Hammar S. P., Asbestos: Risk Assessment, Epidemiology, and Health Effects 2006 Boca Ratton, Fla, USA CRC Press
3. Roggli V. L., Oury T. D., Sporn T. A., Springer Science and Business Media 2004 2nd New York, NY, USA Springer Science and Business Media
4. OByrne K., Rusch V., Malignant Pleural Mesothelioma 2006 New York, NY, USA Oxford University Press
5. Baldi A., Nova Scientific 2008 New York, NY, USA Nova Scientific Publishers
6. Craighead J. E., Craighead J. E., Gibbs A. R., Nonthoracic cancers possibly resulting from asbestos exposure Asbestos and Its Diseases 2008 New York, NY, USA Oxford University Press 230 252
7. Rolston R., Oury D., Roggli V. L., Oury T. D., Sporn T. A., Other neoplasia Pathology of Asbestos-Associated Diseases 2004 2nd New York, NY, USA Springer Science and Business Media 217 230
8. Craighead J. E., Gibbs Al., Pooley F., Craighead J. E., Gibbs A. R., Mineralogy of asbestos Asbestos and Its Diseases 2008 New York, NY, USA Oxford University Press 23 38
9. Roggli V. L., Coin P., Roggli V. L., Oury T. D., Sporn T. A., Mineralogy of asbestos Pathology of Asbestos-Associated Diseases 2004 2nd New York, NY, USA Springer Science and Business Media 1 16
10. Kurumatani N., Kumagai S., Mapping the risk of mesothelioma due to neighborhood asbestos exposure American Journal of Respiratory and Critical Care Medicine 2008 178 6 624 629
11. Kumagai S., Kurumatani N., Asbestos fiber concentration in the area surrounding a former asbestos cement plant and excess mesothelioma deaths in residents American Journal of Industrial Medicine 2009 52 10 790 798
12. Kumagai S., Kurumatani N., Tsuda T., Yorifuji T., Suzuki E., Increased risk of lung cancer mortality among residents near an asbestos product manufacturing plant International Journal of Occupational and Environmental Health 2010 16 3 268 278
13. Yamanaka T., Tanaka F., Hasegawa S., Okada M., Soejima T., Kamikonya N., Fukuoka K., Nakano T., A feasibility study of induction pemetrexed plus cisplatin followed by extrapleural pneumonectomy and postoperative hemithoracic radiation for malignant pleural mesothelioma Japanese Journal of Clinical Oncology 2009 39 3 186 188
14. Hasegawa S., Tanaka F., Malignant mesothelioma: current status and perspective in Japan and the world General Thoracic and Cardiovascular Surgery 2008 56 7 317 323 (Pubitemid 351952058)
15. Ohashi R., Tajima K., Takahashi F., Cui R., Gu T., Shimizu K., Nishio K., Fukuoka K., Nakano T., Takahashi K., Osteopontin modulates malignant pleural mesothelioma cell functions in vitro Anticancer Research 2009 29 6 2205 2214
16. Tabata C., Hirayama N., Tabata R., Yasumitsu A., Yamada S., Murakami A., Iida S., Tamura K., Fukuoka K., Kuribayashi K., Terada T., Nakano T., A novel clinical role for angiopoietin-1 in malignant pleural mesothelioma European Respiratory Journal 2010 36 5 1099 1105
17. Yasumitsu A., Tabata C., Tabata R., Hirayama N., Murakami A., Yamada S., Terada T., Iida S., Tamura K., Fukuoka K., Kuribayashi K., Nakano T., Clinical significance of serum vascular endothelial growth factor in malignant pleural mesothelioma Journal of Thoracic Oncology 2010 5 4 479 483
18. Okumura Y., Tanaka F., Yoneda K., Hashimoto M., Takuwa T., Kondo N., Hasegawa S., Circulating tumor cells in pulmonary venous blood of primary lung cancer patients Annals of Thoracic Surgery 2009 87 6 1669 1675
19. Tanaka F., Yoneda K., Kondo N., Hashimoto M., Takuwa T., Matsumoto S., Okumura Y., Rahman S., Tsubota N., Tsujimura T., Kuribayashi K., Fukuoka K., Nakano T., Hasegawa S., Circulating tumor cell as a diagnostic marker in primary lung cancer Clinical Cancer Research 2009 15 22 6980 6986
20. IARC,International Agency for Research on Cancer, World Health Organization, Silica, some silicate, coal dust and para-aramid fibrils IARC Monographs on the Evaluation of Carcinogenic Risks to Humans 1997 68
21. Heintz N. H., Mossman B. T., Craighead J. E., Gibbs A. R., Molecular responses to asbestos: induction of cell proliferation and apoptosis through modulation of redox-dependent cell signaling pathway Asbestos and Its Diseases 2008 New York, NY, USA Oxford University Press 120 138
22. Atkinson M. A. L., Dodson R. F., Hammar S. P., Molecular and cellular responses to asbestos exposure Asbestos: Risk Assessment, Epidemiology, and Health Effects 2006 Boca Ratton, Fla, USA CRC Press 39 90
23. Caplan A., Rheumatoid disease and pneumoconiosis (Caplan's syndrome) Proceedings of the Royal Society of Medicine 1959 52 1111 1113
24. Caplan A., Payne R. B., Withey J. L., A broader concept of Caplan's syndrome related to rheumatoid factors Thorax 1962 17 205 212
25. Schreiber J., Koschel D., Kekow J., Waldburg N., Goette A., Merget R., Rheumatoid pneumoconiosis (Caplan's syndrome) European Journal of Internal Medicine 2010 21 3 168 172
26. Reiser K. M., Last J. A., Silicosis and fibrogenesis: fact and artifact Toxicology 1979 13 1 51 72 (Pubitemid 10229174)
27. Haustein U. F., Anderegg U., Silica induced sclerodermaClinical and experimental aspects Journal of Rheumatology 1998 25 10 1917 1926 (Pubitemid 28459304)
28. Uber C. L., McReynolds R. A., Immunotoxicology of silica Critical Reviews in Toxicology 1982 10 4 303 320 (Pubitemid 13181646)
29. Steenland K., Goldsmith D. F., Silica exposure and autoimmune diseases American Journal of Industrial Medicine 1995 28 5 603 608
30. Cohen Tervaert J. W., Stegeman C. A., Kallenberg C. G. M., Silicon exposure and vasculitis Current Opinion in Rheumatology 1998 10 1 12 17 (Pubitemid 28058510)
31. Rihova Z., Maixnerova D., Jancova E., Pelclova D., Bartunkova J., Fenclova Z., Vankova Z., Reiterova J., Merta M., Rysava R., Tesar V., Silica and asbestos exposure in ANCA-associated vasculitis with pulmonary involvement Renal Failure 2005 27 5 605 608 (Pubitemid 41216319)
32. Bartukov J., Pelclov D., Fenclov Z., ediv A., Lebedov J., Tesa V., Hladkov M., Kluskov P., Exposure to silica and risk of ANCA-associated vasculitis American Journal of Industrial Medicine 2006 49 7 569 576
33. Wu P., Miura Y., Hyodoh F., Nishimura Y., Hatayama T., Hatada S., Sakaguchi H., Kusaka M., Katsuyama H., Tomita M., Otsuki T., Reduced function of CD4+25+ regulatory T cell fraction in silicosis patients International Journal of Immunopathology and Pharmacology 2006 19 2 357 368 (Pubitemid 44181958)
34. Hayashi H., Maeda M., Murakami S., Kumagai N., Chen Y., Hatayama T., Katoh M., Miyahara N., Yamamoto S., Yoshida Y., Nishimura Y., Kusaka M., Fujimoto W., Otsuki T., Soluble interleukin-2 receptor as an indicator of immunological disturbance found in silicosis patients International Journal of Immunopathology and Pharmacology 2009 22 1 53 62
35. Hayashi H., Miura Y., Maeda M., Murakami S., Kumagai N., Nishimura Y., Kusaka M., Urakami K., Fujimoto W., Otsuki T., Reductive alteration of the regulatory function of the CD4(+)CD25(+) T cell fraction in silicosis patients International Journal of Immunopathology and Pharmacology 2010 23 4 1099 1109
36. Hayashi H., Nishimura Y., Hyodo F., Petro M. E., Dysregulation of autoimmunity caused by silica exposure: fas-mediated apoptosis in T lymphocytes derived from silicosis patients Autoimmune Disorders: Symptoms, Diagnosis and Treatment 2011 Hauppauge, NY, USA Nova Science Publishers 293 301
37. Kumagai N., Hayashi H., Maeda M., Mavragani C., Immunological effects of silica and related dysregulation of autoimmunity Autoimmune Disorder 1 Croatia InTech Open Access Publisher
38. Otsuki T., Hayashi H., Nishimura Y., Hyodo F., Maeda M., Kumagai N., Miura Y., Kusaka M., Uragami K., Dysregulation of autoimmunity caused by silica exposure and alteration of Fas-mediated apoptosis in T lymphocytes derived from silicosis patients International Journal of Immunopathology and Pharmacology 2011 24 1, supplement 11S 16S
39. Nishimura Y., Miura Y., Maeda M., Kumagai N., Murakami S., Hayashi H., Fukuoka K., Nakano T., Otsuki T., Impairment in cytotoxicity and expression of NK cell-activating receptors on human NK cells following exposure to asbestos fibers International Journal of Immunopathology and Pharmacology 2009 22 3 579 590
40. Nishimura Y., Maeda M., Kumagai N., Hayashi H., Miura Y., Otsuki T., Decrease in phosphorylation of ERK following decreased expression of NK cell-activating receptors in human NK cell line exposed to asbestos International Journal of Immunopathology and Pharmacology 2009 22 4 879 888
41. Nishimura Y., Kumagai N., Maeda M., Hayashi H., Fukuoka K., Nakano T., Miura Y., Hiratsuka J., Otsuki T., Suppressive effect of asbestos on cytotoxicity of human NK cells International Journal of Immunopathology and Pharmacology 2011 24 1, supplement 5S 10S
42. Maeda M., Nishimura Y., Kumagai N., Hayashi H., Hatayama T., Katoh M., Miyahara N., Yamamoto S., Hirastuka J., Otsuki T., Dysregulation of the immune system caused by silica and asbestos Journal of Immunotoxicology 2010 7 4 268 278
43. Dostert C., Pétrilli V., Van Bruggen R., Steele C., Mossman B. T., Tschopp J., Innate immune activation through Nalp3 inflammasome sensing of asbestos and silica Science 2008 320 5876 674 677 (Pubitemid 351928351)
44. Cassel S. L., Eisenbarth S. C., Iyer S. S., Sadler J. J., Colegio O. R., Tephly L. A., Carter A. B., Rothman P. B., Flavell R. A., Sutterwala F. S., The Nalp3 inflammasome is essential for the development of silicosis Proceedings of the National Academy of Sciences of the United States of America 2008 105 26 9035 9040
45. Benko S., Philpott D. J., Girardin S. E., The microbial and danger signals that activate Nod-like receptors Cytokine 2008 43 3 368 373
46. Martinon F., Tschopp J., Inflammatory caspases: linking an intracellular innate immune system to autoinflammatory diseases Cell 2004 117 5 561 574 (Pubitemid 38692523)
47. Schroder K., Tschopp J., The Inflammasomes Cell 2010 140 6 821 832
48. Hamilton R. F., Thakur S. A., Holian A., Silica binding and toxicity in alveolar macrophages Free Radical Biology and Medicine 2008 44 7 1246 1258
49. Thakur S. A., Hamilton R. F., Holian A., Role of scavenger receptor A family in lung inflammation from exposure to environmental particles Journal of Immunotoxicology 2008 5 2 151 157 (Pubitemid 351882420)
50. Upadhyay D., Kamp D. W., Asbestos-induced pulmonary toxicity: role of DNA damage and apoptosis Experimental Biology and Medicine 2003 228 6 650 659 (Pubitemid 37163254)
51. Bhattacharya K., Dopp E., Kakkar P., Jaffery F. N., Schiffmann D., Jaurand M. C., Rahman I., Rahman Q., Biomarkers in risk assessment of asbestos exposure Mutation Research 2005 579 1-2 6 21 (Pubitemid 41540129)
52. Liu G., Beri R., Mueller A., Kamp D. W., Molecular mechanisms of asbestos-induced lung epithelial cell apoptosis Chemico-Biological Interactions 2010 188 2 309 318
53. Philip M., Rowley D. A., Schreiber H., Inflammation as a tumor promoter in cancer induction Seminars in Cancer Biology 2004 14 6 433 439 (Pubitemid 39360991)
54. Robinson S. C., Coussens L. M., Soluble mediators of inflammation during tumor development Advances in Cancer Research 2005 93 159 187 (Pubitemid 41557275)
55. Federico A., Morgillo F., Tuccillo C., Ciardiello F., Loguercio C., Chronic inflammation and oxidative stress in human carcinogenesis International Journal of Cancer 2007 121 11 2381 2386 (Pubitemid 350022406)
56. WHO website, Hepatitis C. http://www.who.int/csr/disease/hepatitis/ whocdscsrlyo2003/en/index4.html#incidence
57. WHO website, New and under-utilized vaccines implementation (NUVI), human papillomavirus (HPV). http://www.who.int/nuvi/hpv/en/
58. Hiraku Y., Kawanishi S., Ichinose T., Murata M., The role of iNOS-mediated DNA damage in infection-and asbestos-induced carcinogenesis Annals of the New York Academy of Sciences 2010 1203 15 22
59. Toyokuni S., Mechanisms of asbestos-induced carcinogenesis Nagoya Journal of Medical Science 2009 71 1-2 1 10
60. Toyokuni S., Role of iron in carcinogenesis: cancer as a ferrotoxic disease Cancer Science 2009 100 1 9 16
61. Nagai H., Toyokuni S., Biopersistent fiber-induced inflammation and carcinogenesis: lessons learned from asbestos toward safety of fibrous nanomaterials Archives of Biochemistry and Biophysics 2010 502 1 1 7
62. Miura Y., Nishimura Y., Katsuyama H., Maeda M., Hayashi H., Dong M., Hyodoh F., Tomita M., Matsuo Y., Uesaka A., Kuribayashi K., Nakano T., Kishimoto T., Otsuki T., Involvement of IL-10 and Bcl-2 in resistance against an asbestos-induced apoptosis of T cells Apoptosis 2006 11 10 1825 1835 (Pubitemid 44371055)
63. Otsuki T., Maeda M., Murakami S., Hayashi H., Miura Y., Kusaka M., Nakano T., Fukuoka K., Kishimoto T., Hyodoh F., Ueki A., Nishimura Y., Immunological effects of silica and asbestos Cellular amp; Molecular Immunology 2007 4 4 261 268
64. Maeda M., Miura Y., Nishimura Y., Immunological changes in mesothelioma patients and their experimental detection Clinical Medicine. Circulatory, Respiratory and Pulmonary 2008 2 11 17
65. Romagnani P., Lasagni L., Annunziato F., Serio M., Romagnani S., CXC chemokines: the regulatory link between inflammation and angiogenesis Trends in Immunology 2004 25 4 201 209 (Pubitemid 38372168)
66. Singh U. P., Venkataraman C., Singh R., Lillard J. W., CXCR3 axis: role in inflammatory bowel disease and its therapeutic implication Endocrine, Metabolic and Immune Disorders 2007 7 2 111 123 (Pubitemid 46969859)
67. Fulton A. M., The chemokine receptors CXCR4 and CXCR3 in cancer Current Oncology Reports 2009 11 2 125 131
68. Lacotte S., Brun S., Muller S., Dumortier H., CXCR3, inflammation, and autoimmune diseases Annals of the New York Academy of Sciences 2009 1173 310 317
69. Maeda M., Nishimura Y., Hayashi H., Kumagai N., Chen Y., Murakami S., Miura Y., Hiratsuka J.-I., Kishimoto T., Otsuki T., Decreased CXCR3 expression in CD4+ T cells exposed to asbestos or derived from asbestos-exposed patients American Journal of Respiratory Cell and Molecular Biology 2011 45 4 795 803
70. Maeda M., Nishimura Y., Hayashi H., Reduction of CXCR3 in an in vitro model of continuous asbestos exposure on a human T-cell line, MT-2 American Journal of Respiratory Cell and Molecular Biology 2011 45 3 470 479
71. Murakami S., Nishimura Y., Maeda M., Kumagai N., Hayashi H., Chen Y., Kusaka M., Kishimoto T., Otsuki T., Cytokine alteration and speculated immunological pathophysiology in silicosis and asbestos-related diseases Environmental Health and Preventive Medicine 2009 14 4 216 222
72. Motoyama T., Honma T., Watanabe H., Honma S., Kumanishi T., Abe S., Interleukin 6-producing malignant mesothelioma Virchows Archiv B 1993 64 6 367 372 (Pubitemid 24044406)
73. Kimura N., Ogasawara T., Asonuma S., Hama H., Sawai T., Toyota T., Granulocyte-colony stimulating factor-and interleukin 6-producing diffuse deciduoid peritoneal mesothelioma Modern Pathology 2005 18 3 446 450 (Pubitemid 40395365)
74. Eikawa S., Ohue Y., Kitaoka K., Aji T., Uenaka A., Oka M., Nakayama E., Enrichment of Foxp3+ CD4 regulatory T cells in migrated T cells to IL-6-and IL-8-expressing tumors through predominant induction of CXCR1 by IL-6 Journal of Immunology 2010 185 11 6734 6740
75. Hodge D. R., Hurt E. M., Farrar W. L., The role of IL-6 and STAT3 in inflammation and cancer European Journal of Cancer 2005 41 16 2502 2512 (Pubitemid 41540626)
76. Petersen A. M. W., Pedersen B. K., The role of IL-6 in mediating the anti-inflammatory effects of exercise Journal of Physiology and Pharmacology 2006 57 10 43 51 (Pubitemid 46548766)
77. Heikkil K., Ebrahim S., Lawlor D. A., Systematic review of the association between circulating interleukin-6 (IL-6) and cancer European Journal of Cancer 2008 44 7 937 945
78. Kishimoto T., IL-6: from its discovery to clinical applications International Immunology 2010 22 5 347 352
79. Yokoyama T., Osada H., Murakami H., Tatematsu Y., Taniguchi T., Kondo Y., Yatabe Y., Hasegawa Y., Shimokata K., Horio Y., Hida T., Sekido Y., YAP1 is involved in mesothelioma development and negatively regulated by Merlin through phosphorylation Carcinogenesis 2008 29 11 2139 2146
80. Murakami H., Mizuno T., Taniguchi T., Fujii M., Ishiguro F., Fukui T., Akatsuka S., Horio Y., Hida T., Kondo Y., Toyokuni S., Osada H., Sekido Y., LATS2 is a tumor suppressor gene of malignant mesothelioma Cancer Research 2011 71 3 873 883
81. Sekido Y., Inactivation of Merlin in malignant mesothelioma cells and the Hippo signaling cascade dysregulation Pathology International 2011 61 6 331 344